Magee Thomson Investment Partners’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-70
Closed -$8K 118
2015
Q1
$8K Hold
70
﹤0.01% 43
2014
Q4
$7K Buy
70
+7
+11% +$668 ﹤0.01% 108
2014
Q3
$5K Sell
63
-22
-26% -$1.73K ﹤0.01% 125
2014
Q2
$8K Buy
+85
New +$5.21K ﹤0.01% 112

Other funds holding PTX

Magee Thomson Investment Partners's PTX Position: Q2 2015 in Review

Magee Thomson Investment Partners sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2015, closing a stake of 70 shares — an estimated $8K sold.

Magee Thomson Investment Partners first reported a position in PTX in Q2 2014 and held it in 4 quarters. The position peaked at $8K in Q1 2015. 114 funds tracked by Wall St. Rank hold PTX as of Q2 2015.

  • Magee Thomson Investment Partners reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2015 after selling out during the quarter.
  • Magee Thomson Investment Partners sold 70 Pernix Therapeutics Holdings, Inc. shares in Q2 2015, an estimated $8K.
  • Magee Thomson Investment Partners first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 4 quarters.
  • Magee Thomson Investment Partners's Pernix Therapeutics Holdings, Inc. position peaked at $8K in Q1 2015.
  • 114 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2015.

Based on Magee Thomson Investment Partners's 13F filing for Q2 2015, filed 20 Jul 2015.